Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings
Crossref DOI link: https://doi.org/10.1007/s40256-014-0092-1
Published Online: 2014-10-18
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Verhoef, Talitha I.
Redekop, William K.
Hasrat, Fazila
de Boer, Anthonius
Maitland-van der Zee, Anke Hilse
License valid from 2014-10-18